Decheng Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Nuvation Bionuvationbio.cominNYSE: NUVBJun 2019
Nuvation Bio is a global oncology company that develops novel cancer therapies through its own drug discovery programs and business development, serving cancer patients.
BiotechHealthtechNew York, US
David Hung(Founder)inDavid Hung, M.D.(Executive Officer, Director)inDavid Hanley(Chief Technical Operations Officer)inGary Hattersley(Chief Scientific Officer)inStacy Markel(Chief People Officer)inPhilippe Sauvage(Chief Financial Officer)in
Co-investorsAisling CapitalEcoR1 CapitalVertex Ventures ChinaOmega Funds
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.